{"id":"https://openalex.org/W1908239450","doi":null,"title":"Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.","display_name":"Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.","publication_year":2005,"publication_date":"2005-03-01","ids":{"openalex":"https://openalex.org/W1908239450","mag":"1908239450","pmid":"https://pubmed.ncbi.nlm.nih.gov/15735447"},"language":"en","primary_location":{"id":"pmid:15735447","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15735447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059234144","display_name":"Frank van Leth","orcid":"https://orcid.org/0000-0002-5490-8968","observed_orcids":["https://orcid.org/0000-0002-5490-8968"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Frank van Leth","raw_affiliation_strings":["International Antiviral Therapy Evaluation Center, Department of Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. f.vanleth@iatec.com","University of Amsterdam#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Antiviral Therapy Evaluation Center, Department of Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. f.vanleth@iatec.com","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"University of Amsterdam#N#","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021758906","display_name":"CB Huisamen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Casper B Huisamen","raw_affiliation_strings":["Universite Catholique de Louvain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universite Catholique de Louvain","institution_ids":["https://openalex.org/I95674353","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018655161","display_name":"R.J.S. Badar\u00f3","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088441","display_name":"Complexo Hospitalar Universit\u00e1rio Professor Edgard Santos","ror":"https://ror.org/006k05x61","country_code":"BR","type":"facility","lineage":["https://openalex.org/I4210088441"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Roberto Badaro","raw_affiliation_strings":["C.H.U. Prof. Edgard Santos"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"C.H.U. Prof. Edgard Santos","institution_ids":["https://openalex.org/I4210088441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115599299","display_name":"Bernard Vandercam","orcid":"https://orcid.org/0000-0001-6638-3532","observed_orcids":["https://orcid.org/0000-0001-6638-3532"]},"institutions":[{"id":"https://openalex.org/I4210088441","display_name":"Complexo Hospitalar Universit\u00e1rio Professor Edgard Santos","ror":"https://ror.org/006k05x61","country_code":"BR","type":"facility","lineage":["https://openalex.org/I4210088441"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Bernard Vandercam","raw_affiliation_strings":["C.H.U. Prof. Edgard Santos"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"C.H.U. Prof. Edgard Santos","institution_ids":["https://openalex.org/I4210088441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114037039","display_name":"Joss de Wet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Joss de Wet","raw_affiliation_strings":["University of British Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of British Columbia","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074441717","display_name":"Julio S. G. Montaner","orcid":"https://orcid.org/0000-0002-6201-9829","observed_orcids":["https://orcid.org/0000-0002-6201-9829"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Julio S G Montaner","raw_affiliation_strings":["University of British Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of British Columbia","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David B Hall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B Hall","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103228162","display_name":"Ferdinand W.N.M. Wit","orcid":"https://orcid.org/0000-0003-2066-8115","observed_orcids":["https://orcid.org/0000-0003-2066-8115"]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ferdinand W N M Wit","raw_affiliation_strings":["University of Amsterdam#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Amsterdam#N#","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113507629","display_name":"Joep M. A. Lange","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Joep M A Lange","raw_affiliation_strings":["University of Amsterdam#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Amsterdam#N#","institution_ids":["https://openalex.org/I887064364"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2951,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.78410672,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"38","issue":"3","first_page":"296","last_page":"300"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.023000000044703484,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-rna","display_name":"HIV-1 RNA","score":0.7630000114440918},{"id":"https://openalex.org/keywords/viral-load-decline","display_name":"viral load decline","score":0.7239999771118164},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.9549999833106995},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":1.0},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8370000123977661},{"id":"https://openalex.org/keywords/early-treatment-efficacy","display_name":"early treatment efficacy","score":0.5289999842643738},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.7279999852180481},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.8700000047683716},{"id":"https://openalex.org/keywords/stavudine","display_name":"stavudine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.921206533908844},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.9093494415283203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7044334411621094},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.6851819753646851},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.6236372590065002},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6197547316551208},{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.6055446267127991},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.597641110420227},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.47233477234840393},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.44995173811912537},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4359198212623596},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.4202956557273865},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3762286901473999},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3757818639278412},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.33367788791656494},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.28979432582855225},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.26884955167770386},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.1306658387184143},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.05154469609260559},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"pmid:15735447","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15735447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Clinical Trial"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/3a8caa34-27fc-4139-b9a4-a5514ed7837f","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/plasma-hiv1-rna-decline-within-the-first-two-weeks-of-treatment-is-comparable-for-nevirapine-efavirenz-or-both-drugs-combined-and-is-not-predictive-of-longterm-virologic-efficacy--a-2nn-substudy(3a8caa34-27fc-4139-b9a4-a5514ed7837f).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999), 38(3), 296 - 300. Lippincott Williams and Wilkins","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:39515","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/39515","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAIDS, Vol. 38, no. 3, p. 296-300 (2005)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/2913ba07-8e7a-461d-b06e-4edf6d1b3e9e","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/2913ba07-8e7a-461d-b06e-4edf6d1b3e9e","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Leth, F, Huisamen, C B, Badaro, R, Vandercam, B, de Wet, J, Montaner, J S G, Hall, D B, Wit, F W N M & Lange, J M A 2005, 'Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy - A 2NN substudy', Journal of acquired immune deficiency syndromes (1999), vol. 38, no. 3, pp. 296-300.","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:1908239450","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15735447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1951712651","https://openalex.org/W1964490015","https://openalex.org/W1973398091","https://openalex.org/W2011630381","https://openalex.org/W2022098233","https://openalex.org/W2029455319","https://openalex.org/W2043281109","https://openalex.org/W2044403736","https://openalex.org/W2051269276","https://openalex.org/W2057826571","https://openalex.org/W2059778842","https://openalex.org/W2103773011","https://openalex.org/W2103934625","https://openalex.org/W2116258000","https://openalex.org/W2124177834","https://openalex.org/W2125946310","https://openalex.org/W2130154289","https://openalex.org/W2141776019","https://openalex.org/W2155449170","https://openalex.org/W2157390600","https://openalex.org/W2163500912","https://openalex.org/W2163828009","https://openalex.org/W2329241680"],"related_works":["https://openalex.org/W2076456853","https://openalex.org/W4229548811","https://openalex.org/W1965602853","https://openalex.org/W2125946310","https://openalex.org/W2020845967","https://openalex.org/W1717567909","https://openalex.org/W2144282683","https://openalex.org/W2130154289","https://openalex.org/W1997321745","https://openalex.org/W2116419666"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,86,192],"initial":[2],"rate":[3,33],"of":[4,16,19,27,34,60,71,148,157,182,190,200],"plasma":[5,140],"HIV-1":[6],"RNA":[7],"(pVL)":[8],"decline":[9,36,184],"has":[10],"been":[11],"proposed":[12],"as":[13],"a":[14,24,112,129,145],"marker":[15],"early":[17],"efficacy":[18],"antiretroviral":[20],"therapy":[21,158],"(ART)":[22],"and":[23,55,104,177],"possible":[25],"predictor":[26],"late":[28,201],"efficacy.":[29,203],"We":[30],"compared":[31],"the":[32,61,67,77,155,186],"pVL":[35,114,183],"in":[37,50,73,76,173],"patients":[38,74],"starting":[39],"ART":[40],"with":[41,111,139,144,175,194],"nevirapine":[42],"(NVP),":[43],"efavirenz":[44],"(EFV),":[45],"or":[46,143,169],"both":[47],"drugs":[48],"combined":[49],"addition":[51],"to":[52,127],"lamivudine":[53],"(3TC)":[54],"stavudine":[56],"(d4T).":[57],"METHODS:":[58],"Analysis":[59],"viral":[62],"decay":[63],"constant":[64],"(VDc)":[65],"during":[66,185],"first":[68,187],"2":[69,188],"weeks":[70,189],"treatment":[72],"enrolled":[75],"2NN":[78],"study":[79],"who":[80],"remained":[81],"on":[82],"allocated":[83],"treatment.":[84,191],"RESULTS:":[85],"median":[87],"VDc":[88,130,135,193],"(log10":[89],"copies":[90],"per":[91],"day,":[92],"[interquartile":[93],"range])":[94],"was":[95,136],"similar":[96,180],"for":[97],"NVP":[98,105,170],"(0.30":[99,108],"[0.25-0.36],":[100],"EFV":[101,107,172],"(0.31":[102],"[0.27-0.37]),":[103],"+":[106,171],"[0.27-0.36]).":[109],"Patients":[110],"baseline":[113],">100,000":[115],"copies/mL":[116],"were":[117],"8.7":[118],"(95%":[119],"confidence":[120],"interval":[121],"[CI]:":[122],"6.2-12.3)":[123],"times":[124],"more":[125],"likely":[126],"have":[128],">75th":[131],"percentile.":[132],"A":[133],"high":[134],"not":[137,198],"associated":[138],"drug":[141],"concentration":[142],"decreased":[146],"risk":[147],"virologic":[149,202],"failure":[150],"at":[151],"week":[152],"48":[153],"after":[154],"start":[156],"(hazard":[159],"ratio":[160],"=":[161],"0.8,":[162],"95%":[163],"CI:":[164],"0.6-1.2).":[165],"CONCLUSION:":[166],"NVP,":[167],"EFV,":[168],"combination":[174],"3TC":[176],"d4T":[178],"show":[179],"rates":[181],"these":[195],"regimens":[196],"is":[197],"predictive":[199]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}